tiprankstipranks
Trending News
More News >
Perspective Therapeutics (CATX)
:CATX
US Market

Perspective Therapeutics (CATX) Financial Statements

Compare
1,608 Followers

Perspective Therapeutics Financial Overview

Perspective Therapeutics's market cap is currently $507.00M. The company's EPS TTM is $-0.51; its P/E ratio is -1.97; Perspective Therapeutics is scheduled to report earnings on March 16, 2026, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Jun 22Jun 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 1.43M$ 7.10M$ 10.79M
Gross Profit$ 0.00$ 0.00$ 1.43M$ 1.63M$ 4.62M
Operating Income$ 9.14M$ 10.46M$ -40.94M$ -15.18M$ -7.39M
EBITDA$ 9.14M$ 10.46M$ -39.96M$ -14.84M$ -7.39M
Net Income$ -103.12M$ -79.28M$ -46.51M$ -14.67M$ -7.15M
Balance Sheet
Cash & Short-Term Investments$ 144.74M$ 226.92M$ 9.24M$ 43.76M$ 60.35M
Total Assets$ 266.97M$ 341.10M$ 97.89M$ 58.09M$ 67.25M
Total Debt$ 1.63M$ 4.06M$ 2.55M$ 0.00$ 652.00K
Net Debt$ -29.00M$ -57.52M$ -6.69M$ -20.99M$ -59.70M
Total Liabilities$ 59.94M$ 50.43M$ 22.71M$ 3.45M$ 2.86M
Stockholders' Equity$ 207.03M$ 290.67M$ 75.18M$ 54.64M$ 64.39M
Cash Flow
Free Cash Flow$ -95.23M$ -72.71M$ -37.98M$ -12.47M$ -7.98M
Operating Cash Flow$ -82.48M$ -18.29M$ -36.91M$ -12.17M$ -7.71M
Investing Cash Flow$ 41.23M$ -218.93M$ 24.37M$ -57.68M$ -284.00K
Financing Cash Flow$ 10.30M$ 289.38M$ 785.00K$ 56.00K$ 56.00K
Currency in USD

Perspective Therapeutics Earnings and Revenue History

Perspective Therapeutics Debt to Assets

Perspective Therapeutics Cash Flow

Perspective Therapeutics Forecast EPS vs Actual EPS